Medical News

RSS

Breakthrough in understanding mechanisms behind hereditary alpha-1-antitrypsin deficiency

Researchers from the Royal College of Surgeons in Ireland (RCSI) and Beaumont Hospital have made a breakthrough in understanding the mechanisms behind the most severe form of hereditary emphysema and how protein treatments can improve the condition. The findings of this study may also lead to new treatments for patients with smoker's emphysema.

24 Jan 2011

First Edition: January 24, 2011

Today's health policy news includes reports foreshadowing possible Senate action on repealing the health overhaul.

24 Jan 2011

Contagious cancer repairs own genetic mutations

A curious contagious cancer, found in dogs, wolves and coyotes, can repair its own genetic mutations by adopting genes from its host animal, according to a new study in the journal Science.

24 Jan 2011

Mathematical models to predict fatigue could reduce risk of accidents

Washington State University sleep researchers have determined that the air traffic controller in the crash of a Lexington, Ky., commuter flight was substantially fatigued when he failed to detect that the plane was on the wrong runway and cleared it for takeoff.

24 Jan 2011

KineMed's fibrosis research program featured in Nature Medicine

KineMed Inc.'s fibrosis research program, which aims to advance the discovery and development of drugs to treat this major disease, is featured in the January edition of Nature Medicine.

24 Jan 2011

Northwest Biotherapeutics resumes enrollment in DCVax Phase II clinical trial for GBM brain cancer

Northwest Biotherapeutics announced today that the Company is resuming enrollment of additional new patients into its ongoing 240-patient, double blind, randomized, placebo controlled Phase II clinical trial of DCVax for Glioblastoma multiforme brain cancer.

24 Jan 2011

AnC Bio Holdings invests $4 million in Bioheart

Bioheart, Inc. announced today that it has entered into an agreement with AnC Bio Holdings, Inc., a South Korean biomedical company, and one of its U.S. agents for a $4 million equity investment. Bioheart has designated proceeds from the investment to advance the current clinical evaluation of its cell therapies for treating heart failure and related cardiac diseases.

24 Jan 2011

BDSI refutes MonoSol's patent infringement claims relating to BEMA Buprenorphine

BioDelivery Sciences International, Inc. today responded to a process patent infringement lawsuit filed and recently served against the Company and certain co-defendants by MonoSol Rx, LLC. The purpose in responding at this time is for BDSI to strongly refute MonoSol's claims and to assure BDSI stockholders that the Company remains focused on vigorously progressing its pipeline and not allowing this claim to present a distraction.

24 Jan 2011

Alqaem and Biosign to exhibit UFIT TEN-20 non-invasive glucometer at 36th Arab Health Exhibition

ALQAEM International, exclusive Biosign master distributor for the Middle East and North Africa Region (M.E.N.A.) today announced that they will be joining with Biosign Technologies Inc, the Canadian manufacturer of the revolutionary UFIT TEN-20 non-invasive glucometer, to exhibit at the 36th Annual Arab Health Exhibition & Congress held in Dubai, UAE from January 24th to 27th, 2011 at Stand S1G61.

24 Jan 2011

Exiqon launches new Hi-Power microRNA labeling kits

Exiqon, a leading supplier of high-value gene expression analysis products, today announced the launch of the 3rd generation of miRCURY LNA microRNA Labeling Kit called Hi-Power for labeling of microRNAs for downstream hybridization to microRNA arrays.

24 Jan 2011

Raptor completes enrollment in DR Cysteamine Phase 3 clinical trial in cystinosis

Raptor Pharmaceutical Corp., today announced it has completed enrollment in its Phase 3 clinical trial of its proprietary delayed-release oral formulation of cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis").

24 Jan 2011

Family Research Council calls for legislative action and increased oversight of abortion clinics

Family Research Council is demanding answers, increased oversight and legislative action in the wake of the arrest of Dr. Kermit Gosnell, a Philadelphia abortionist charged with eight counts of murder, including a patient and seven newborn infants.

24 Jan 2011

Conservative Republicans officially release funding reduction plan that includes cutting USAID budget

Foreign Policy's blog "The Cable" reports on Thursday's call by a group of "conservative House Republicans ... for a drastic defunding of the U.S. Agency for International Development and a host of other programs" (Rogin, 1/20).

24 Jan 2011

Healthcare workers can help improve quality of life for end of life patients

Healthcare workers can most directly affect quality of life (QOL) of patients with advanced stage lung cancer by helping manage symptoms such as pain, lack of energy, shortness of breath, coughing, difficulty sleeping and dry mouth, according to a study recently published in the journal Oncology Nursing Forum.

24 Jan 2011

Nutrient 'biomarkers' may help assess nutrient status of elderly people at risk for dementia

Research is trying to determine whether Alzheimer's disease might be slowed or prevented with nutritional approaches, but a new study suggests those efforts could be improved by use of nutrient "biomarkers" to objectively assess the nutrient status of elderly people at risk for dementia.

24 Jan 2011

Elsevier, Robert Koch Institute partner for systematic posting of manuscripts in institutional repositories

Elsevier, the world-leading publisher of scientific, technical and medical information products and services, and the Robert Koch Institute announced they have entered into a two-year trial agreement enabling researchers at Robert Koch Institute to systematically post their manuscripts in the institutional repository.

24 Jan 2011

FDA approves Clinical Data's Viibryd for major depressive disorder

Clinical Data, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved vilazodone HCl tablets, to be marketed under the brand name Viibryd™, for the treatment of adults with major depressive disorder (MDD).

24 Jan 2011

PHA concerned over negative impact on patient care by Section 6001 of Healthcare Reform

Physician Hospitals of America (PHA) is deeply concerned about the negative impact on patient care caused by Section 6001 of Healthcare Reform which prohibits new construction or expansion of physician owned hospitals (POHs). Since its passage, section 6001 has prevented or impeded progress for 37 new hospitals, more than 40 nearly-finished hospital construction projects, and approximately 20 major expansion projects.

24 Jan 2011

Mystery of 'inactive' defensin solved

Under standard laboratory conditions, the human beta-defensin 1 (hBD-1), a human antibiotic naturally produced in the body, had always shown only little activity against microbes. Nevertheless the human body produces it in remarkable quantities.

24 Jan 2011

Positive interim data from ongoing V5 Phase IIb imm01 trial against tuberculosis

Immune Network, a company in the business of development and commercialization of immune therapies, announced today that its newly acquired business, Immunitor, has published interim data from the ongoing Phase IIb imm01 clinical trial of V5 in tuberculosis conducted at its second site in Ukraine.

24 Jan 2011

Medical News

Breakthrough in understanding mechanisms behind hereditary alpha-1-antitrypsin deficiency

First Edition: January 24, 2011

Contagious cancer repairs own genetic mutations

Mathematical models to predict fatigue could reduce risk of accidents

KineMed's fibrosis research program featured in Nature Medicine

Northwest Biotherapeutics resumes enrollment in DCVax Phase II clinical trial for GBM brain cancer

AnC Bio Holdings invests $4 million in Bioheart

BDSI refutes MonoSol's patent infringement claims relating to BEMA Buprenorphine

Alqaem and Biosign to exhibit UFIT TEN-20 non-invasive glucometer at 36th Arab Health Exhibition

Exiqon launches new Hi-Power microRNA labeling kits

Raptor completes enrollment in DR Cysteamine Phase 3 clinical trial in cystinosis

Family Research Council calls for legislative action and increased oversight of abortion clinics

Conservative Republicans officially release funding reduction plan that includes cutting USAID budget

Healthcare workers can help improve quality of life for end of life patients

Nutrient 'biomarkers' may help assess nutrient status of elderly people at risk for dementia

Elsevier, Robert Koch Institute partner for systematic posting of manuscripts in institutional repositories

FDA approves Clinical Data's Viibryd for major depressive disorder

PHA concerned over negative impact on patient care by Section 6001 of Healthcare Reform

Mystery of 'inactive' defensin solved

Positive interim data from ongoing V5 Phase IIb imm01 trial against tuberculosis

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News